Ra
Non verificato

Ray Therapeutics

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza
06/10/2026
Scienza
Medicina - Varie
Biotecnologia
Sanità
Salute
Farmaceutica
Ottica
Ray Therapeutics Celebrates 2026 Nobel Prize for Foundational Discoveries in Optogenetics
1.00
30/09/2026
Infanzia
Biologia
Biotecnologia
Salute
Farmaceutica
Ottica
Scienza
Vetrine/Shopping
Medicina - Varie
Ray Therapeutics Awarded $8 Million CIRM Grant to Advance RTx-021 Gene Therapy for Stargardt Disease
1.00
21/05/2026
Mercato del lavoro
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Ray Therapeutics Expands Board Expertise with Appointment of Vikas Sinha, MBA as Director and Chair of the Audit Committee
1.00
29/04/2026
Industria
Scienza
Igiene alimentare
Biotecnologia
Medicina - Varie
Farmaceutica
Salute
Ottica
Ray Therapeutics Granted Priority Medicines (PRIME) Designation from the European Medicines Agency for RTx-015 in Retinitis Pigmentosa
1.00
21/04/2026
Industria
Biotecnologia
Salute
Farmaceutica
Ottica
Medicina - Varie
Ray Therapeutics Announces Upsized and Oversubscribed $125 Million Series B Financing for Vision Restoration Treatments
1.00
01/04/2026
Industria
Biotecnologia
Igiene alimentare
Sanità
Salute
Ottica
Scienza
Medicina - Varie
Ray Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RTx-015 in Retinitis Pigmentosa
1.00
17/02/2026
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Mercato del lavoro
Ray Therapeutics Appoints Michael Murtagh as Chief Regulatory Officer
1.00
08/01/2026
Mercato del lavoro
Biotecnologia
Ottica
Salute
Medicina - Varie
Ray Therapeutics Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors
1.00
24/04/2025
Mercato del lavoro
Industria
Scienza
Biotecnologia
Medicina - Varie
Biologia
Farmaceutica
Salute
Ottica
Ray Therapeutics Awarded $8M CIRM Grant to Advance RTx-015 Gene Therapy for Retinitis Pigmentosa
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0